Aktienbewertung
Konkurrenz
| Ticker | Preis | Prognose 1J | Prognose 2J | Börsenwert | Div Yld | Wachstumsrate |
|---|---|---|---|---|---|---|
|
NYSE:LLY
Eli Lilly and
|
760.00 | -48,06% | -26,74% | 684.308,09 | 0,68% | 2,63% |
|
NYSE:JNJ
Johnson & Johnson
|
149.91 | 0% | 0% | 360.785,28 | 3,31% | 2,71% |
|
NYSE:MRK
Merck
|
130.06 | -9,24% | 4,07% | 329.416,79 | 2,37% | -19,03% |
|
NYSE:ABBV
AbbVie
|
160.75 | -20,35% | -9,82% | 283.863,25 | 3,86% | 7,03% |
|
LSE:AZN
AstraZeneca PLC
|
123.70 | 16,41% | 38,64% | 191.764,07 | 2% | 15,98% |
|
NYSE:PFE
Pfizer
|
28.01 | 10,84% | 41,72% | 158.721,27 | 6% | -9,31% |
|
ENXTPA:SAN
Sanofi
|
94.33 | 12,8% | 30,73% | 117.784,75 | 3,99% | 8,19% |
|
NYSE:BMY
Bristol-Myers Squibb
|
44.94 | 58,46% | 68,59% | 91.097,88 | 5,34% | 13,54% |
|
LSE:RKT
Reckitt Benckiser Group
|
45.97 | 41,25% | 58,23% | 32.354,18 | 4,19% | -1,02% |
|
NYSE:TEVA
Teva Pharmaceutical Industries
|
16.25 | -46,07% | -42,6% | 18.405,41 | 0% | -2,6% |
|
NasdaqGS:VTRS
Viatris Inc
|
11.16 | 5,13% | 15,66% | 13.324,53 | 4,3% | -8,55% |
|
BSE:500257
Lupin
|
1609.85 | 31,56% | 59,36% | 722.022,1 | 0,5% | 14,97% |
|
NasdaqGS:JAZZ
Jazz Pharmaceuticals
|
109.63 | 53,71% | 67,56% | 7.131,04 | 0% | 5,95% |
|
NasdaqGS:ITCI
Intra-Cellular Therapies
|
64.96 | 0% | 0% | 6.858,14 | 0% | 0% |
|
CPSE:HLUN A
H. Lundbeck A/S
|
34.58 | 93,43% | 119,8% | 33.294,43 | 2,02% | 32,92% |
|
NasdaqGS:INSM
Insmed
|
25.97 | 0% | 0% | 3.918,89 | 0% | 0% |
|
LSE:INDV
Indivior PLC
|
14.32 | -23,61% | -1,68% | 1.952,43 | 0% | -2,7% |
|
NasdaqCM:TGTX
TG Therapeutics
|
16.62 | 0% | 0% | 2.379,32 | 0% | 0% |
|
NasdaqGM:SUPN
Supernus Pharmaceuticals
|
28.96 | 2,87% | 17,34% | 1.720,68 | 0% | -11,07% |
|
SWX:COPN
Cosmo Pharmaceuticals N.V.
|
70.80 | -8,78% | 50,69% | 1.136,54 | 2,76% | -76,88% |
